Using Bioptron Light Therapy to Treat Dry Eyes in Postmenopausal Women
Effect of Bioptron Light Therapy on Dryness of Eyes in Postmenopausal Women
This study is testing if Bioptron light therapy can help relieve dry eye symptoms in postmenopausal women better than just providing education about the condition.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 50 Years to 65 Years |
| Sex | Female |
| Sponsor | Cairo University Academic / other |
| Locations | 1 site (Cairo,) |
| Trial ID | NCT05964673 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the effectiveness of Bioptron light therapy in alleviating dry eye symptoms in postmenopausal women. A total of 60 participants will be randomly assigned to two groups: one receiving only patient education and the other receiving both education and Bioptron light therapy over four weeks. The study aims to assess improvements in symptoms and overall eye health. The approach focuses on enhancing capillary circulation and immune response to relieve dryness and discomfort.
Who should consider this trial
Good fit: Ideal candidates are postmenopausal women over 50 years old experiencing mild to moderate dry eye symptoms.
Not a fit: Patients with chronic eye conditions, autoimmune diseases, or those undergoing hormone replacement therapy may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could significantly improve the quality of life for postmenopausal women suffering from dry eye disease.
How similar studies have performed: While there is limited data on Bioptron light therapy specifically for dry eyes, similar light therapies have shown promise in treating various eye conditions.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All participants are postmenopausal women. * Their age above 50 years old * All participants aren't on any systematic therapy. Exclusion Criteria: * • Injuries and previous surgical treatment of eyes * All patients with diagnosis of chronic blepharitis, meibominitis or any other eye infections * Participants with autoimmune diseases such as Sjögren's syndrome (SS), rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) * Diabetic participants will be excluded. * Smokers will be excluded from the study. * The use of Hormone Replacement Therapy
Where this trial is running
Cairo,
- Cairo University — Cairo,, Egypt (Recruiting)
Study contacts
- Principal investigator: Sara Ahmed, lecturer — giza, Egypt, 12511
- Study coordinator: Sara Ahmed, lecturer
- Email: Saramagdy87@cu.edu.eg
- Phone: 01063998331
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.